Clinical Trials Logo

Hip Fractures clinical trials

View clinical trials related to Hip Fractures.

Filter by:

NCT ID: NCT03795467 Active, not recruiting - Ileus Clinical Trials

Peripheral Perfusion Index, Haemoglobin and Blood Transfusion in Acute Surgical Patients

Start date: November 1, 2017
Phase:
Study type: Observational

The peripheral perfusion index (PPI) is a non-invasive, feasible measure of peripheral perfusion and, assumed, the overall circulation, which all patients are monitored by. This study is carried out to assess the association between values of PPI, haemoglobin and blood transfusion. Hypothetically, patients with low values of hb are more susceptible to a deteriorating circulation reflected in poorer PPI regardless of blood pressure and that resuscitation with blood products improves PPI measurements. Moreover, that patients with low values of PPI have more surgical complications and higher mortality.

NCT ID: NCT03776526 Recruiting - Delirium Clinical Trials

Researching the Effects of Sleep on STep Count dUring the Postoperative Period

REST-UP
Start date: March 1, 2018
Phase:
Study type: Observational

Patients over the age of 65 who are admitted to the Juravinski Hospital for treatment of hip fractures will be invited to take part in the study. An activity monitor (a Fitbit® Alta HR) will be attached to the participant post-operatively, to record quality of sleep and amount of activity for the duration of hospital stay. The time spent in hospital and whether complications or confusion develops will also be recorded. The aim is to determine whether poor sleep affects recovery after hip fracture surgery.

NCT ID: NCT03757442 Active, not recruiting - Ileus Clinical Trials

Peripheral Perfusion Index in Acute Surgical Patients

Start date: April 1, 2017
Phase:
Study type: Observational

The PPI is a non-invasive, feasible measure of peripheral perfusion and, assumed, the overall circulation, which all patients are monitored by. This study is carried out to assess the association between values of PPI, postoperative complications and mortality. This study seeks to establish acceptable perioperative values with the possibility of basing and improving perioperative optimization and resuscitation treatment algorithms on PPI possibly reducing complications and mortality in the future.

NCT ID: NCT03749122 Completed - Surgery Clinical Trials

Time to Hip Fracture Surgery

Start date: January 1, 2006
Phase:
Study type: Observational

The purpose of the study is to evaluate how time from hospital admission to start of surgery influence mortality in patients with acute hip fracture. Data on patients with hip fracture surgery will be collected from the hospital's registration system and will be analyzed regarding age, gender, American Society of Anesthesiologists (ASA) Physical Status Classification, type of surgery and time from admission to surgery along with data on mortality.

NCT ID: NCT03695081 Recruiting - Aging Clinical Trials

Patient Pathway Pharmacist - Optimal Drug-related Care

Start date: September 3, 2018
Phase: N/A
Study type: Interventional

Medication errors represent the most common cause of patient injury and one of the most frequently reported health related deviation in Norway. The addition of a dedicated clinical pharmacist throughout the hip fracture patient pathway (patient pathway pharmacist) is believed to improve patient safety and ensure optimal drug-related patient care. The pharmacist will perform medication reconciliation at admission to hospital, medication review after surgery and assist physicians with discharge summary. Six weeks after discharge the patient pathway pharmacist will perform a second drug reconciliation and medication review. This study will assess the pharmacists' place and specific tasks in the patient pathway, describe areas where the pharmacist contribute to increased quality of care and assess the benefits and/or disadvantages experienced with introducing a patient pathway pharmacist. The estimated number of patients included is 60. Current practice will be determined by investigating the last 50 patients' medical record and a questionnaire to health care professionals involved in treatment of hip fracture patients. Data from medication reconciliation and drug review will be collected and compared to current practice. After the inclusion period, focus group surveys and/or semi-structured interviews will be executed to describe the perceived improvement in the quality of care. Primary endpoints are: 1) Medication reconciliation score at admission 2) Number of inappropriate drugs for elderly 3) Discharge summary score 4) Discharge summaries following procedure. Secondary endpoints are readmissions and mortality after 30 and 90 days. Qualitative endpoints: 1) Health care professionals experience of current drug-related practice 2) Experienced advantages and disadvantages of a patient pathway pharmacist.

NCT ID: NCT03685110 Recruiting - Clinical trials for Degenerative Osteoarthritis

CoreHip - Post Market Clinical Follow-Up Study

Start date: October 16, 2018
Phase:
Study type: Observational

The study is designed as a prospective, non-interventional multicentre cohort study. The product under Investigation will be used in Routine clinical practice and according to the authorized Instructions for Use (IfU). Aim of this observational study is to collect clinical and radiological results of the CoreHip® endoprosthesis system in a Standard Patient Population and when used in Routine clinical practice.

NCT ID: NCT03680014 Not yet recruiting - Hip Fractures Clinical Trials

Remote Monitoring and Analysis of Gait and Falls Within an Elderly Population

4279
Start date: September 12, 2018
Phase:
Study type: Observational [Patient Registry]

The investigators aim to do this initial pilot study as an observational prospective cohort study, evaluating elderly patients who have capacity in National Health Service (NHS) rehabilitation and community hospitals. The patients will each be recorded doing simple activities of daily living in two 2 hour sessions using a discrete wireless device. This will generate anonymous data set that can be used to train and refine our machine learning algorithm.

NCT ID: NCT03670290 Not yet recruiting - Hip Fractures Clinical Trials

Clinical Outcomes of Analgesia Methods in Patients With Hip Fracture

Start date: December 15, 2018
Phase:
Study type: Observational

The goal of this study is to determine of clinical outcomes of analgesia methods. This study will evaluate clinical outcomes with "Revised APS Patient Outcome Questionnaire (APS-POQ)"

NCT ID: NCT03648775 Recruiting - Osteoporosis Clinical Trials

Evaluation of the Clinical Efficacy of Y-STRUT® Medical Device Implanted for Contralateral Percutaneous Internal Fixation of Proximal Femur, in Patient With a Low Energy Per Trochanteric Fracture on the First Side

Start date: December 6, 2017
Phase:
Study type: Observational

HIP50 is a national, multicentre, prospective, observational study, in patients presenting a first low energy per trochanteric hip fracture on one side and treated with Y-STRUT® device implanted on the contralateral proximal femur as percutaneous internal fixation to prevent contralateral hip fracture in case of osteoporosis. The primary objective of this study is to evaluate the clinical efficacy of the studied medical device by measuring the frequency of patient with a fracture at the implantation site within 1 year after implantation. A total of 50 patients from France will be enrolled (until December 2018) and followed up to 24 months.

NCT ID: NCT03647436 Recruiting - Depression Clinical Trials

Incidence of Geriatric Syndromes Overlap

Start date: August 1, 2018
Phase:
Study type: Observational

The overlap of depression and delirium as geriatric syndromes present in elderly patients with hospital admission due to hip fracture has been previously studied. Nevertheless, the relationships between these two clinical processes and other geriatric syndromes, especially malnutrition, have not been studied. For this reason, a prospective cohort study has been designed to know the differences in the incidence of geriatric syndromes during hospital admission due to hip fracture in patients with and without risk of malnutrition.